| COVID-19 and RAAS blockers: Could Aliskiren be an appropriate option? | Selçuk ŞEN, Ali Yağız ÜRESİN | 631–634 |
| Cardiovascular system and COVID-19 | Serap ŞİMŞEK YAVUZ | 635–639 |
| Effect of the COVID-19 pandemic on access to primary percutaneous coronary intervention for ST-segment elevation myocardial infarction | Mert HAYIROĞLU, İlker TEKKESİN, Göksel ÇİNİER, Levent PAY, Ahmet YUMURTAŞ, Ozan TEZEN, Kemal Emrecan PARSOVA | 640–645 |
| Efficacy and safety of carotid artery stenting: Experience of a single center | Hüseyin AYHAN, Bilge DURAN KARADUMAN, Telat KELEŞ, Engin BOZKURT | 646–655 |
| The CHA2DS2-VASc score and in-hospital mortality in patients with COVID-19: A multicenter retrospective cohort study | Samir ALLAHVERDİYEV, Alaa QUİSİ, Hazar HARBALIOĞLU, Gökhan ALICI, Ömer GENÇ, Abdullah YILDIRIM, İbrahim Halil KURT, Fahri ER | 656–663 |
| Comparison of RCHA2DS2-VASc score and CHA2DS2-VASc score prediction of no-reflow phenomenon in patients with ST-segment elevation myocardial infarction | Cemal KÖSEOĞLU, Çağrı ZORLU | 664–672 |
| Investigation of metabolic effects of CETP gene rs289714 variation in coronary artery patients: A case-control study | Özlem KURNAZ GÖMLEKSİZ, Zehra BUĞRA, Oğuz ÖZTÜRK, Hülya YILMAZ AYDOĞAN, Zeynep KARAALİ | 673–682 |
| Serum lactate level may predict the development of acute kidney injury in acute decompensated heart failure | Çetin GEÇMEN, Ahmet KARADUMAN, Cevat KIRMA, Yusuf YILMAZ, Ahmet GÜNER, Emrah BAYAM, İbrahim Akın İZGİ, Muzaffer KAHYAOĞLU, Özkan CANDAN, Ender Özgün ÇAKMAK, Mehmet ÇELİK | 683–689 |
| High fructose consumption may be associated with slow coronary flow | Mevlüt Serdar KUYUMCU, Aliye KUYUMCU | 690–697 |
| A case of heart failure mimicking COVID-19 pneumonia: The role of clinical and chest computed tomography findings in the differential diagnosis | Bülent MUTLU, Çiğdem İLERİ, Zekeriya DOĞAN, Çağan YILDIRIM, Halil ATAŞ, Altuğ ÇİNÇİN, Beste ÖZBEN | 698–702 |
| A rare presentation of a patient with COVID-19: Cardiac tamponade |